MedTrace Logo

Significance of Immunohistochemical Expression of Fascin-1 in Colorectal Carcinoma

NCT05553080 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2023-04-12

No results posted yet for this study

Summary

Colorectal carcinoma is a major health problem. As a malignant tumor, the malignant potential of colorectal carcinoma is based mainly on its ability to metastasis to different sites. Fascin-1 is an actin binding protein which is involved in reconstruction of intracellular actin network, the latter enforces the neoplastic cell to invade surrounding structures.

Conditions

  • Cancer of Colon

Interventions

GENETIC

Immunohistochemistry

immunohistochemical staining of colorectal carcinoma specimens by anti human fascin antibody.

Sponsors & Collaborators

  • Sohag University

    lead OTHER

Eligibility

Min Age
30 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2022-09-30
Completion
2022-12-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05553080 on ClinicalTrials.gov